James Johnston

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

Sarah Diver, Latifa Khalfaoui, Claire Emson et al. · The Lancet Respiratory Medicine · 2021 · 314 citations

Pharmacy, Immunology, Pharmacotherapy +12

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

John R. Teerlink, G. Michael Felker, John J.V. McMurray et al. · The Lancet · 2016 · 293 citations · Full text

Medicine, Cardiology, Physiology +10

Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma

Laszlo Kari, Andrey Loboda, Michael Nebozhyn et al. · The Journal of Experimental Medicine · 2003 · 208 citations · Full text

Medicine, Hematology, Oncology +14

Double-blind evaluation of intradiscal chymopapain for herniated lumbar discs

P. Robert Schwetschenau, Archimedes Ramirez, James Johnston et al. · Journal of neurosurgery · 1976 · 82 citations

Medicine, Pharmacotherapy, Surgery +16